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Abstract
Background: Substance use disorder is an important public health problem and one of the major causes of
disability worldwide. Substance use and criminal behavior are closely related and there is a significant association
between substance misuse and crime, but little is known about substance use disorder among prisoners, in
particular in low-income countries. Therefore, we investigated substance use disorder and associated factors in
inmates of a correctional institution in Jimma, Southwest Ethiopia.
Methods: We used a cross-sectional study design to collect data from 336 prisoners from June 5 to July 5, 2017.
Study participants were selected from the total of 1460 prisoners eligible for the study by a systematic random
sampling technique, i.e., one participant was randomly selected from every four consecutive admissions in the
registration book. Alcohol use disorder, nicotine dependence, khat abuse, cannabis use disorder, psychopathy,
adverse traumatic life events, and social support were assessed. Data were entered into EpiData version 3.1 and
analyzed in bivariate and multivariable logistic regression models with the Statistical Package for Social Science
version 21. Variables with a P value < 0.05 in the final fitting model were declared to be associated with the
outcome variable.
Results: The overall prevalence of substance use disorder was 55.9%. The prevalence of khat abuse was 41.9%;
alcohol use disorder, 36.2%; nicotine dependence, 19.8%; and cannabis use disorder, 3.6%. Poor social support,
living in urban areas, psychopathy, and a family history of substance use were positively associated with substance
use disorder.
Conclusions: Substance use disorder is prevalent among prisoners. The increased morbidity and unpleasant
psychosocial consequences associated with substance use disorder, together with our finding that 66.3% of
prisoners with substance use disorder were interested in obtaining treatment, suggest a need to establish
prison-based treatment in this correctional institution in Jimma.
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Background
According to a WHO 2014 report, alcohol consumption,
accounted for 5.9% of all deaths worldwide in the year
2012 [1]. Also, smoking caused more than one in ten
deaths global, killing more than 6 million people in 2015
[2]. The report also found that the global use of these
substances is growing rapidly and contributes signifi-
cantly to the global burden of disease, assessed as
disability-adjusted life years [3, 4]. It estimated that
substance use accounted for 14.7% of disability-adjusted
life years in 2010 (alcohol: 6.9%) [4].
Substance use and criminal behavior are closely
related, and a large proportion of substance users
commit crimes while under the influence of a
substance [5]. Substance use significantly increases
the likelihood of arrest because it increases the need
to commit crimes to obtain money to buy a particular
substance [5]. Furthermore, 37% of almost 2 million
convicted offenders currently in jail were drinking at
the time of their arrest [6]. According to a U.S. De-
partment of Justice report, in 2004 about one-third
(32%) of inmates in state facilities reported that they
had committed a crime while under the influence of
drugs [6]. Alcohol is a factor in 40% of all violent
crimes in the USA [5], and alcohol and other drugs
contribute to 78% of violent crimes, 83% of property
crimes, and 77% of public order crimes [7]. Inmates
with substance abuse problems are more likely to be
re-incarcerated, begin their criminal careers at an
early age and have more contact with the criminal
justice system [7]. Additionally, prisoners with sub-
stance abuse problems are four times more likely to
receive income through illegal activities [7].
The risk factors for substance use disorder include
a family history of substance use; personality traits,
such as high impulsivity or sensation seeking; depres-
sion and anxiety; exposure to physical, sexual, or
emotional abuse or trauma; and starting substance
use at an early age [8]. Rounds-Bryant and Baker [9]
stated that ongoing substance abuse in prisoners is a
concern because if prisoners are not given adequate
treatment in prison and supervision is lacking in the
community after they are discharged they have a high
potential to become re-addicted and commit a crime
after their release. Furthermore, community samples
do not necessarily reflect samples in custodial set-
tings, where histories of drug and alcohol use are par-
ticularly high compared with the general population
[9]. Because a better understanding of this situation
could help to highlight the need for different services
to meet prisoners’ needs, a systematic review studied
the prevalence of problematic substance use and types
of substance use disorder diagnosis among people ad-
mitted to prison [10].
The review found that 24% of the studied population
met the criteria for alcohol use disorder (AUD) and 30%
of male and 51% of female prisoners had a drug use
disorder [10].
Prison-based drug treatment is diverse and includes a
wide range of treatment programs, such as psychosocial-
behavioral interventions, therapeutic communities, and
victim impact panels, interventions involving legal sanc-
tions, and group and individual psychotherapy for
drug-abusing offenders [11]. One study found that 20.5%
of prisoners who had completed in-prison residential
treatment used drugs or alcohol compared with 36.7% of
untreated prisoners within the first six month after
release [12].
Despite the contribution of substance use disorder to
the global burden of diseases and the high prevalence
among incarcerated people, little attention is given to
this disorder in the general population and among
prisoners in particular [9]. This is particularly true in
low-income countries; in Ethiopia, for example, no study
has examined the prevalence of substance use disorder
in a prison population. Therefore, this study aimed to
assess the prevalence of this disorder and associated




The prison is managed by the Oromiya Regional
Correcting Units Administrative Office. It was put into
service after the expulsion of the occupying Italian forces
in 1943 and serves the following regions: Oromiya,
Southern nations and nationalities, and Gambella region.
The facility was built to accommodate 450 prisoners but
currently houses about 1460 (1418 male and 42 female).
It is designated as a maximum-security facility. The
prison population includes offenders on remand and
people convicted to a limited or life-long sentence. The
prison compound houses a medical clinic and sick bay,
in addition to the usual prison facilities. The study was
conducted from June 5 to July 5, 2017.
Study design
This was a cross-sectional study conducted in the
correctional institution in Jimma, Southwest Ethiopia
Sampling technique
We used a systematic random sampling technique to
select participants. The total number of prisoners was
used as a sampling frame. About 1460 prisoners were
eligible for the study, and the sampling interval was
1460/336 = 4. The first prisoner was randomly selected
from the first four prisoners listed in the registration
book according to their date of entry into the prison.
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We then continued to select one prisoner from every
subsequent group of 4 until the required sample size
was reached (n = 336).
Sample size
The sample size (n) was calculated by the single popula-
tion proportion formula, n = (Zalpha/2)2 * P (1-P)/d2
[13], assuming a prevalence (P) of 50%, i.e. 0.5 (because
a priori prevalence of 0.5 yields a maximally conservative
estimate for the required sample size and no similar
study has been performed among a prison population in
Ethiopia or any other African country), a 95% confidence
interval (CI) of 1.96 (Zalpha/2 = 1.96), a 5% margin of
error (d, 0.05), and a non-response rate of 10%.
We applied the single population proportion formula
to give n = (1.96)2 * [0.5 (1–0.5)]/0.052 = 384. Because
the population size is < 10,000, we used the finite popu-
lation correction formula with the calculated sample size




¼ 384= 1þ 384=1460½ ð Þ ¼ 305
Thus, assuming a 10% non-response rate the final
sample size was 336.
Study procedures
Data were collected by five Master of Science in
Psychiatry students. All data collectors were given
two-day training on the study objectives, data collection
methods, tools, methods for maintaining confidentiality,
acquisition of informed consent, and handling of ethical
issues. The five students were supervised by two Master
of Science in Public Health students and the principal
investigator. A pre-test was conducted on 5% of the
sample in the Agaro prison, which is located 45 km from
Jimma. On each day of data collection, the completed
questionnaires were checked for completeness. The col-
lected data were entered into a computer and processed
in a timely fashion.
We assessed the presence of four substance use disor-
ders: AUD, khat abuse, nicotine dependence, and canna-
bis use disorder. To identify AUD, we used the Alcohol
Use Disorders Identification Test (AUDIT) [14]. An
AUDIT score ≥ 8 is considered to indicate an AUD. The
sensitivity and specificity of AUDIT for AUD are 0.90
and 0.80, respectively [14], and the reliability in this
study was 0.87 (Cronbach’s α). We assessed nicotine
dependence with the Fagerstrom Test for Nicotine
Dependence (FTND), in which a score ≥ 1 indicates
nicotine dependence [15]. The reliability of the FTND in
this study was 0.80 (Cronbach’s α). To evaluate khat
abuse, we used the Drug Abuse Screening Test (DAST);
a score ≥ 3 indicates abuse [16]. The reliability of the
DAST in this study was 0.88 (Cronbach’s α). Finally, we
used the Cannabis Use Problems Identification Test
(CUPIT) to assess cannabis use disorder; a score ≥ 12
indicates a cannabis use disorder [17]. The reliability of
CUPIT in this study was 0.87 (Cronbach’s α). We chose
those tools to assess substance use disorder because they
were previously used in similar populations [18].
We used a questionnaire to assess the following poten-
tial explanatory variables for substance use disorder: so-
cioeconomic factors (age, sex, marital status, ethnicity,
religion, educational status, occupation, income); envir-
onmental factors (family history of substance use, social
support, immigration history); behavioral and mental
health factors (previous known mental illness, percep-
tion that substance use does not impair health, start of
substance use at an early age, chronic physical illness,
suicidal ideation and attempts); and criminal factors
(previous arrest, previous substance-related offences,
type of crime, committed a crime under the influence of
a substance). We chose to explore these variables
because an earlier study found that they are relevant for
substance use disorder [7, 19]. We also assessed social
support with the Oslo 3-item Social Support Scale [20],
psychopathy with the Psychopathy Checklist: Screening
Version (PCL: SV; cut-off score ≥ 13 [21]; sensitivity,
0.94; specificity, 0.85; reliability in this study: Cronbach’s
α = 0.86), and adverse traumatic life events with the Life
Events Checklist (positive if at least one traumatic event
recorded).
Lastly, we used a 4-item questionnaire to gather data
on other aspects of substance use: 1. which reason(s) ex-
plain(s) why you use the substance? (possible responses:
[A] To relax; [B] To relieve stress; [C] To be accepted by
peers (peer pressure); [D] To feel normal; [E] For confi-
dence to commit an offence; [F] Others [specify]); 2.
Have you been treated for a substance use disorder?
([A]Yes; [B] No); 3. Are you interested in receiving treat-
ment for substance use disorder? ([A] Yes; [B] No); 4.
Are you interested in continuing to take the substance
after you are released from prison? ([A] Yes; [B] No).
Data processing and analysis
EpiData Version 3.1 was used to enter the data; the
mean was used in case of missing data. Then, the
data were exported to Statistical Package for Social
Science version 21.0 for further analysis. Descriptive
statistics, such as the frequency and median, were
computed, and bivariate and multivariable analyses
were used to identify factors associated with the out-
come variable. Factors associated with the outcome
variables that had a P value < 0.25 in the bivariate
analysis were included in the multivariable analysis.
Statistical significance was set at P < 0.05. An odds
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ratio with a 95% CI was computed to assess the level
of association and statistical significance.
Ethical considerations
The study protocol was approved by the Research Ethics
and Approval Committee of the Jimma University Insti-
tute of Health, and the study was performed according
to the Declaration of Helsinki. Verbal informed consent
was obtained from prisoners. Participants were told that
selection for participation in the study was random and
that they had the right not to respond to questions they
were not comfortable with and to ask questions. After




A total of 329 prisoners participated in the study. The
response rate was 97.9%: of the 336 prisoners
approached to participate in the study, n = 7 (2.1%)
declined to participate because they were unwilling to be
interviewed about their substance use histories. The me-
dian age of the participants was 26 years (inter-quartile
range [IQR] 14). The majorities of participants had been
residing in urban areas before imprisonment and were
unmarried. The most common ethnicity was Oromo,
and the most common religion, Muslim. Detailed infor-
mation on socio-demographic characteristics is given in
Table 1.
Prevalence of substance use disorder
A total of n = 227 (69.0%) of the participants had a
history of substance use. More than half of all partici-
pants (n = 184/329, 55.9%) reported a substance use
disorder within the 12 months before imprisonment,
and half (n = 165/329, 50.2%) had used a substance
within the 30 days before imprisonment.
Khat was the most commonly used substance in the
12 months before imprisonment, (n = 138/329, 41.9%).
Among the participants with khat abuse, n = 81(58.7%)
had harmful use, and n = 57 (41.3%), khat dependence.
The prevalence of AUD within the 12 months before im-
prisonment was 36.2% (n = 119/329). Among the partici-
pants with an AUD, n = 57 (47.9%) had hazardous
drinking; n = 20 (16.8%), harmful drinking; and n = 42
(35.2%), alcohol dependence. The next most commonly
used substance was nicotine: n = 65/329 (19.8%) of
participants had a history of nicotine dependence within
the 12 months before imprisonment (low dependence:
n = 28, 43.1%; low to moderate dependence: n = 10,
15.4%; moderate dependence: n = 22 (33.8%); and high
dependence: n = 5 (7.7%). The prevalence of cannabis
use disorder within the 12 months before imprison-
ment was 3.6% (n = 13/329).
A total of n = 105 participants (31.9%) had a history of
two or more substance use disorders. Among the pris-
oners with an AUD, n = 87 (73.1%) had a history of khat
abuse; n = 41 (34.5%), a history of nicotine dependence;
and n = 13 (10.9%), a history of cannabis use disorder.
Among the prisoners with khat abuse, n = 87 (63%) had
a history of AUD; n = 43 (31.2%), a history of nicotine
dependence; and n = 13 (9.4%), a history of cannabis use
disorder. Among the prisoners with nicotine depend-
ence, n = 43 (66.2%) had a history of khat abuse; n = 41
(63.1), a history of AUD; and n = 12 (18.5%), a history of
cannabis use disorder.
The median age at the first use of a substance was
16 years (IQR 5), and 44% of the participants started
using the substance before the age of 15 years. The
median duration of substance use was 6 years (IQR 7).
The main reasons for starting substance use reported
by participants were peer pressure (n = 77, 41.8%), recre-
ational reasons (n = 63, 34.2%), and stress relief (n = 54,
29.3%). Almost all of the prisoners with a substance use
disorder had not received treatment prior to imprison-
ment (n = 178, 96.7%), but n = 122 (66.3%) of them were
interested in receiving treatment. A third (n = 62, 33.7%),
however, wanted to continue using the substance after
they were released from prison.
Among the prisoners with a substance use disorder,
the most common reasons for imprisonment were as-
sault (n = 65, 35.3%) and theft (n = 47, 25.5%). The most
common reasons for imprisonment among participants
with an AUD, nicotine dependence, or cannabis use
disorder were assault (n = 42, 35.3%; n = 24, 36.9%; and
n = 5, 38.5%, respectively) and murder (n = 28, 23.5%;
n = 12, 26.2%; and n = 4, 30.8%, respectively), and among
prisoners with khat abuse, assault (n = 48, 34.8%) and theft
(n = 38, 27.5%).
Prison history
The median age of participants at the first imprison-
ment was 24 years (IQR 13). Nearly all of the partici-
pants were convicted prisoners. At the time of the
study, the median duration of incarceration was
48 months (IQR 90) and the median duration of time
spent in prison was 9 months (IQR 20).
Assault and murder were the most common causes of
imprisonment. Most of the participants had no previous
history of imprisonment, and most of the crimes were
not committed under the influence of a substance.
Among the crimes that were committed under the
influence of a substance (n = 42/329), n = 24 (57.1%)
were committed under the influence of alcohol; n = 14
(33.3%), under the influence of khat; and n = 4 (9.6%),
under the influence of cannabis. Table 2 shows the study
participants’ forensic history. See (Table 2)
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Factors associated with substance use disorder
Various behavioral, mental health, environmental, and
criminal factors were found to be associated with
substance use disorder (see Table 3).
Multivariable logistic regression showed that four
variables were significantly associated with substance use
disorder: poor social support (adjusted odds ratio
[AOR]: 4.41; 95% CI, 2.22–8.77), living in an urban set-
ting (AOR: 2.42; 95% CI, 1.33–4.40), psychopathy (AOR:
4.68; 95% CI, 1.71–12.78), and a family history of sub-
stance use (AOR: 4.39; 95% CI, 2.49–7.79). Prisoners
with poor social support were more than four times
more likely to develop a substance use disorder than
prisoners with good social support (AOR:4.41; 95% CI,
2.22–8.77). Also, prisoners living in an urban setting
were more than two times more likely to have a
substance use disorder than prisoners living in a rural
setting (AOR:2.42; 95% CI, 1.33–4.40). Prisoners with
psychopathy were nearly five times more likely to de-
velop a substance use disorder than those without
psychopathy (AOR: 4.68; 95% CI, 1.71–12.78). Prisoners
with a family history of substance use were more than
Table 1 Socio-demographic characteristics of prisoners in the correctional institution in Jimma, Southwest Ethiopia, June–July 2017
(n = 329) and bivariate analysis of socio-demographic characteristics
Variables Category Frequency Percentage (%) Substance use disorder COR (95% CI) P value
No (%) Yes (%)
Sex Male 307 93.3 130 (42.3) 177 (57.7) 2.92 (1.16–7.36) 0.023a
Female 22 6.7 15 (68.2) 7 (31.8) Reference value
Age categories < 30 219 66.6 98 (44.7) 121 (55.3) 1.52 (0.49–4.67) 0.465
≥ 30 110 33.4 47 (42.7) 63 (57.3) Reference value
Place of residence Rural 106 32.2 60 (56.6) 46 (43.4) Reference value
Urban 223 67.8 85 (38.1) 138 (61.9) 2.12 (1.32–3.39) 0.002a
Ethnicitya Oromo 210 63.8 – – – –
Amhara 51 15.5 – – – –
Tigray 16 4.9 – – – –
Gurage 17 5.2 – – – –
Dawuro 17 5.2 – – – –
Yem 16 4.9 – – – –
Otherb 2 0.6 – – – –
Educational status No formal education 27 8.2 11 (40.7) 16 (59.3) Reference value
Primary education 178 54.1 83 (46.6) 95 (53.4) 0.79 (0.35–1.79) 0.568
Secondary education 94 28.6 41 (43.6) 53 (56.4) 0.89 (0.37–2.12) 0.790
Tertiary education 30 9.1 10 (33.3) 20 (66.7) 1.38 (0.47–4.05) 0.563
Religion Muslim 181 55.0 79 (43.6) 102 (56.4) 2.91 (0.86–9.78) 0.085a
Orthodox 97 29.5 40 (41.2) 57 (58.8) 3.21 (0.92–1.14) 0.067a
Protestant 38 11.6 17 (44.7) 21 (55.3) 2.78 (0.73–0.62) 0.135a
Catholic 13 4.0 9 (69.2) 4 (30.8) Reference value
Marital status Married 124 37.7 58 (46.8) 66 (53.2) Reference value
Unmarried 205 62.3 87 (42.4) 118 (57.6) 1.19 (0.76–1.87) 0.443
Occupation Employed 134 40.7 62 (46.3) 72 (53.7) Reference value
Unemployed 36 10.9 14 (38.9) 22 (61.1) 1.35 (0.64–2.87) 0.430
Farmer 99 30.1 40 (40.4) 59 (59.6) 1.27 (0.75–2.15) 0.373
Student 43 13.1 22 (51.2) 21 (48.8) 0.82 (0.41–1.64) 0.576
Otherc 17 5.2 7 (41.2) 10 (58.8) 1.23 (0.44–3.43) 0.692
Average monthly income (birr) < 1200 192 58.4 81 (42.2) 111 (57.8) Reference value
≥1200 137 41.6 64 (46.7) 73 (53.3) 0.83 (0.54–1.29) 0.415
Reference value: In the analysis, this variable indicated lower risk for developing substance use; coded as zero in SPSS logistic regression
aBivariate analysis was not performed for ethnicities
bOther ethnicities: kafa, walayita, and silte
cOther occupations: retired or homemaker
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Table 2 Forensic history of prisoners (n = 329) in the correctional institution in Jimma, Southwest Ethiopia, in June–July 2017
Variables Frequency Percentage (%) Substance use disorder
No, n (%) Yes, n (%)
Reason for admission to prison On remand 25 7.6 15 (60.0) 10 (40.0)
Convicted 304 92.4 130 (42.8) 174 (57.2)
Type of offence committed Assault 103 31.3 38 (36.9) 65 (63.1)
Murder 83 25.2 41 (49.4) 42 (50.6)
Theft 81 24.6 34 (42.0) 47 (58.0)
Rape 32 9.7 16 (50.0) 16 (50.0)
Robbery 12 3.6 5 (41.7) 7 (58.3)
Othera 18 5.4 11 (61.1) 7 (38.9)
Previous imprisonment No 301 91.5 140 (46.5) 161 (53.5)
Yes 28 8.5 5 (17.9) 23 (82.1)
Committed crime under the influence of substance No 287 87.2 140 (48.4) 147 (51.6)
Yes 42 12.8 5 (11.9) 37 (88.1)
aOther types of offence = political offence and offence related to forest destruction
Table 3 Bivariate analysis of behavioral, mental health, environmental, and criminal factors among prisoners in the correctional
institution in Jimma, Southwest Ethiopia, June–July 2017 (n = 329)
Variable Substance use disorder COR (95% CI) P value
No (%) Yes (%)
Psychopathy No 139 (48.3) 149 (51.7) Reference value
Yes 6 (14.6) 35 (85.4) 5.44 (2.22–13.34) 0.001*
Adverse traumatic life event No exposure to traumatic life event 62 (51.7) 58 (48.3) Reference value
One traumatic life event 33 (52.4) 30 (47.6) 0.97 (0.53–1.79) 0.927
Multiple traumatic life events 50 (34.2) 96 (65.8) 2.05 (1.25–3.37) 0.004*
Mental illness No 132 (44.3) 166 (55.7) Reference value
Yes 13 (41.9) 18 (58.1) 1.10 (0.52–2.33) 0.801
Social support Poor 53 (28.8) 131 (71.2) 4.35 (2.42–7.81) 0.001*
Moderate 48 (63.2) 28 (36.8) 1.03 (0.52–2.02) 0.939
Strong 44 (63.8) 25 (36.2) Reference value
Immigration No 123 (45.6) 147 (54.4) Reference value
Yes 22 (37.3) 37 (62.7) 1.40 (0.79–2.51) 0.248*
Previous imprisonment No 140 (46.5) 161 (53.5) Reference value
Yes 5 (17.9) 23 (82.1) 4.00 (1.48–10.80) 0.006*
Family history of substance use No 110 (57.0) 83 (43.0) Reference value
Yes 35 (25.7) 101 (74.3) 3.82 (2.37–6.17) 0.001
Suicidal ideation and suicide attempt No 114 (46.9) 129 (53.1) Reference value
Yes 31 (36.0) 55 (64.0) 1.57 (0.94–2.60) 0.082*
Chronic physical illness No 120 (43.5) 156 (56.5) Reference value
Yes 25 (47.2) 28 (52.8) 0.86 (0.48–1.55) 0.62
Perceived that substance use did not affect health No 66 (46.5) 76 (53.5) Reference value
Yes 79 (42.2) 108 (57.8) 1.19 (0.77–1.84) 0.444
Reference value: In the analysis, this variable indicated lower risk for developing substance use; coded as zero in SPSS logistic regression
*Identified as factors for multivariable logistic regression analysis (P < 0.25)
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four times more likely to have a substance use disorder
than prisoners with no family history of substance use
(AOR: 4.39; 95% CI, 2.49–7.79) (see Table 4).
Discussion
This cross-sectional study assessed the prevalence of
substance use disorder among prisoners in a correctional
facility in Jimma, Southwest Ethiopia, in the 12 months
before imprisonment. The prevalence of substance use
disorder was 55.9%, which is similar to a comparable
study performed in Australia (66%) [22].
The prevalence of AUD among prisoners in the
current study was in line with a similar study performed
Sudan (32.2%, N = 1569) [23] but lower than the preva-
lence found in a Finnish study (68%, N = 610) [24]. The
difference might be due to differences in sample size and
the tool used to assess AUD (the Finnish study used a
clinical psychiatric interview in a larger sample). A
study performed in a prison in Lyon, France, found a
lower prevalence of AUD (13.7%, N = 535) [25], which
may be because it was performed in women only and
the participants may have had other differences in
socio-demographic characteristics.
The prevalence of khat abuse found in the current
study was much higher than that in a study in
Uganda (17%) [26]. However, the Ugandan study used
a self-report questionnaire, so khat use may have
been underreported.
The prevalence of nicotine dependence among the
prisoners in the current study in the 12 months before
imprisonment was lower than the findings of studies in
Kenya (32.7%) [27] and Lyon (37.5%) [25]. The
differences might be due to the different tools used to
measure nicotine dependence and differences between
the study populations (the Kenyan study used a
self-report questionnaire, and the study in Lyon was in
female participants only).
The presence of psychopathy was significantly associ-
ated with substance use disorder. This finding is in line
with similar studies performed in England and Wales
[28] and Turkey [29], both of which found that psychop-
athy was associated with substance use disorder. The
reason for this association might be that people with
psychopathy have an irresponsible lifestyle, are impul-
sive, curious to try new things and unconventional and
show sensation-seeking behavior, which in turn makes
them more likely to use a substance as a form of
self-medication [28].
In the current study, prisoners who lived in an urban
setting had a higher likelihood of developing a substance
use disorder than those who lived in a rural setting. This
finding is in line with a similar study performed in
Kenya [27]. This difference might be explained by
various characteristics of urban environments, such as
population density, built-up environments, and greater
access to substances [30].
Both in our study and in a study performed in incar-
cerated delinquents in Nigeria [31], a family history of
substance use was associated with the prisoners’
substance use disorder. Prisoners with a family history of
substance use had a more than four times higher likeli-
hood of developing a substance use disorder than those
with no such family history. One reason for this associ-
ation might be that parents with a history of substance
use may not be deeply involved in bringing up their fam-
ily and may be less attached to their family, so that their
children have difficulties in learning social behavior
patterns and experience more adverse life events [32].
Furthermore, families may have a genetic susceptibility
to substance use, and it may also be a learned behavior.
The implication of this finding is that substance use
awareness campaigns should target not only prisoners
but also their parents and relatives.
Prisoners with poor social support were more likely to
develop a substance use disorder than those with good
Table 4 Multivariable logistic regression analysis for independent predictors of a substance use disorder among prisoners (n = 329)
in a correctional institution in Jimma, Southwest Ethiopia, in June–July 2017
Variable Substance use disorder AOR (95% CI)
No, n (%) Yes, n (%)
Social support Poor support 53 (28.8) 131 (71.2) 4.41 (2.22–8.77)
Moderate support 48 (63.2) 28 (36.8) 1.07 (0.49–2.34)
Strong support 44 (63.8) 25 (36.2) Reference value
Family history of substance use No 110 (57.0) 83 (43.0) Reference value
Yes 35 (25.7) 101 (74.3) 4.39 (2.49–7.79)
Psychopathy No 139 (48.3) 149 (51.7) Reference value
Yes 6 (14.6) 35 (85.4) 4.68 (1.71–12.78)
Place of residence Rural 60 (56.6) 46 (43.4) Reference value
Urban 85 (38.1) 138 (61.9) 2.42 (1.33–4.40)
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social support. A study performed in Hungary also
found that poor social support, in the form of poor sup-
port from the father, was a factor for substance use [33].
Social support has been found to help people cope with
stress and to reduce the risk for anxiety, depression, and
distress, all of which are risk factors for substance use
[34]. Thus, people with poor social support might be
that at greater risk of using substances. Furthermore,
people may be more likely to use substances if they have
no one to live for other than themselves. This may also
apply to people who do not receive any feedback and
criticism from others because such feedback and criti-
cism could help them form socially acceptable behavior.
Our finding that just over half of all prisoners had a
substance use disorder within 12 months prior to their
imprisonment is alarming in view of the fact that sub-
stance use disorder treatment is not accessible in the
prison. If current prevalence rates are generalizable to all
prisons in Ethiopia, our results suggest that about two
thirds of prisoners with substance use disorder are
interested in receiving treatment; however, almost no
prisoners with substance use disorder have access to
such treatment services. With regard to the treatment of
substance use disorder in prison, therapeutic community
intervention (TCI) and individual and group therapy are
methods that can decrease the rates of re-incarceration,
drug misuse relapse, and re-arrest [35]. Research has
shown that an unfortunate consequence of this short-
age of treatment services is that offenders quickly
return to drug use and crime after their release from
prison [36, 37].
In summary, this study has substantial clinical implica-
tions for health services in correctional institutions be-
cause it shows the need for management plans for acute
substance withdrawal and for recovery and rehabilitation
support for prisoners with substance use disorder.
Limitations
This study may have a social desirability bias, i.e. pris-
oners may have underestimated, underreported or de-
nied their substance use. Also, data on the previous
12 months were collected by interview, which has a risk
of recall bias. DAST was not validated in our population,
even though it has been shown to be useful in screening
for khat abuse across cultures. Another limitation is that
prisoners’ reports of past or present physical illness and
mental illness were not clinically confirmed.
Conclusions
This study found a high prevalence of substance use
disorder among prisoners in a correctional institution in
Jimma, Southwest Ethiopia, in the 12 months before
imprisonment. The most commonly used substance was
khat, followed by alcohol, nicotine, and cannabis. Living
in an urban setting and having psychopathy, a family
history of substance use, and poor social support were
positively associated with substance use disorder. Gener-
ally, despite the increased morbidity of substance users
and unpleasant psychosocial consequences of this habit,
most prisoners reported not receiving treatment prior to
imprisonment. The large number of prisoners with
substance use disorder, the unavailability of treatment in
prisons, and the substantial gap in services relative to
the need indicate that prisoners are more likely to return
to risky substance use after release from prison. There-
fore, increasing access to substance use disorder treat-
ment, such as TCI, in prison could have substantial
long-term economic and social benefits, e.g. reduced
recidivism, easier transition to the community after
release, and less drug abuse [38].
Further research is needed into substance abuse in
other correctional institutions in Ethiopia and the
efficacy of prison-based treatment for substance use
disorder.
Abbreviations
AOR: Adjusted odds ratio; AUD: Alcohol use disorder; AUDIT: Alcohol Use
Disorders Identification Test; CUPIT: Cannabis Use Problems Identification
Test; DAST: Drug Abuse Screening Test; FTND: Fagerstrom Test for Nicotine
Dependence; IQR: Interquartile range
Acknowledgments
We would like to thank Jimma University for granting ethical approval and
funding the study. Our deep thanks go to all study participants, who spent
their valuable time responding to the questions in this study. We also thank
Jacquie Klesing, Board-certified Editor in the Life Sciences (ELS), for editing
assistance with the manuscript.
Funding
The study was funded by Jimma University. The University had no role in the
design of the study; in the collection, analysis, and interpretation of the data;
or in writing the manuscript.
Availability of data and materials
The datasets generated and analyzed during the current study is an ongoing
project and we will make the datasets available to organizations and
individuals based on official request.
Authors’ contributions
YY wrote the protocol, participated in data collection, analyzed the data and
wrote the manuscript. MS and KA participated in conception of the project,
data analysis, reviewing and editing of the manuscript. MA, ET and AM made
substantial contributions to data analysis, revising and approving the
protocol. All authors read and approved the final manuscript.
Ethics approval and consent to participate
The study protocol was approved by the Research Ethics and Approval
Committee of the Jimma University Institute of Health. Verbal informed




The authors declare that they have no competing interests.
Yitayih et al. BMC Psychiatry  (2018) 18:314 Page 8 of 9
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Psychiatry, College of Health Sciences, Jimma University,
Jimma, Ethiopia. 2Center for International Health,
Ludwig-Maximilians-Universität, Munich, Germany. 3Department of Psychiatry
and Psychotherapy, Medical Center of the University of Munich, Munich,
Germany. 4Institute of Psychiatric Phenomics and Genomics (IPPG), Medical
Center of the University of Munich, Munich, Germany.
Received: 3 April 2018 Accepted: 20 September 2018
References
1. World Health Organization, World Health Organization. Management of
Substance Abuse Unit. Global status report on alcohol and health,
2014. In: World Health Organization; 2014.
2. Reitsma MB, Fullman N, Ng M, Salama JS, Abajobir A, Abate KH, Abbafati C,
Abera SF, Abraham B, Abyu GY, Adebiyi AO. Smoking prevalence and
attributable disease burden in 195 countries and territories, 1990–2015: a
systematic analysis from the Global Burden of Disease Study 2015.
Lancet. 2017;389(10082):1885–906.
3. Charlson FJ, Baxter AJ, Dua T, Degenhardt L, Whiteford HA, Vos T.
Excess mortality from mental, neurological and substance use disorders
in the global burden of disease study 2010. Epidemiol Psychiat Sci.
2015;24(2):121–40.
4. Whiteford H, Ferrari A, Degenhardt L. Global burden of disease studies:
implications for mental and substance use disorders. Health Aff.
2016;35(6):1114–20.
5. National Council on Alcoholism and Drug Dependence, Inc. Alcohol, Drugs
and Crime https://www.ncadd.org/about-addiction/alcohol-drugs-and-
crime. Accessed 9 Jan 2018.
6. Mumola CJ, Karberg JC. Drug use and dependence, state and Federal
Prisoners, 2004. Washington, DC: US Department of Justice, Office of Justice
Programs; 2006.
7. The National Center on Addiction and Substance Abuse at Colombia
University. Behind Bars II: Substance Abuse and America’s Prison Population.
https://www.centeronaddiction.org/addiction-research/reports/behind-bars-
ii-substance-abuse-and-america%E2%80%99s-prison-population.
Accessed 9 Jan 2018.
8. Addiction Risk Factors | The National Center on Addiction and Substance
Use. https://www.centeronaddiction.org/addiction/addiction-risk-factors.
Accessed 8 Jan 2018.
9. Rounds-Bryant JL, Baker L Jr. Substance dependence and level of treatment
need among recently-incarcerated prisoners. Am J Drug Alcohol Abuse.
2007;33:557–61.
10. Fazel S, Yoon IA, Hayes AJ. Substance use disorders in prisoners: an updated
systematic review and meta-regression analysis in recently incarcerated
men and women. Addiction. 2017;112(10):1725–39.
11. Roberts AJ, Hayes AJ, Carlisle J, Shaw J. Review of drug and alcohol
treatments in prison and community settings. In: A systematic review
conducted on the behalf of the prison Health Research network. England:
Prison Health Research network, Department of Health; 2007.
12. Pelissier B, Wallace S, O'Neil JA, Gaes GG, Camp S, Rhodes W, Saylor W.
Federal prison residential drug treatment reduces substance use and arrests
after release. Am J Drug Alcohol Abuse. 2001;27(2):315–37.
13. Charan J, Biswas T. How to calculate sample size for different study designs
in medical research? Indian J Psychol Med. 2013;35(2):121.
14. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT. The alcohol
use disorders identification test. Guidelines for use in primary care. 2nd ed.
Geneva: World Health Organization; 2001.
15. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström
test for nicotine dependence: a revision of the Fagerström tolerance
questionnaire. Br J Addict. 1991;86:1119–27.
16. Wazema DH, Madhavi K. Prevalence of Khat abuse and associated factors
among undergraduate students of Jimma University. Ethiopia Int J Res Med
Sci. 2017;3:1751–7.
17. Bashford J, Flett R, Copeland J. The Cannabis use problems identification
test (CUPIT): development, reliability, concurrent and predictive validity
among adolescents and adults. Addiction. 2010;105:615–25.
18. MacAskill S, Parkes T, Brooks O, Graham L, McAuley A, Brown A. Assessment
of alcohol problems using AUDIT in a prison setting: more than an’aye or
no’question. BMC Public Health. 2011;11(1):865.
19. Kilpatrick DG, Acierno R, Saunders B, Resnick HS, Best CL, Schnurr PP. Risk
factors for adolescent substance abuse and dependence: data from a
national sample. J Consult Clin Psychol. 2000;68(1):19.
20. Bøen H, Dalgard OS, Bjertness E. The importance of social support in the
associations between psychological distress and somatic health problems
and socio-economic factors among older adults living at home: a cross
sectional study. BMC Geriatr. 2012;12:27.
21. Hart SD, Cox DN, Hare RD. Manual for the hare psychopathy checklist:
screening version (PCL: SV). Multi-Heath Systems: Toronto, Canada; 1995.
22. Heffernan E, Davidson F, Andersen K, Kinner S. Substance use disorders
among aboriginal and Torres Strait islander people in custody: a public
health opportunity. Health Justice. 2016;4:12.
23. Karim E-FIA, Mohamed HM, Mohamed MI, Ahmed AF, Mohammed SAA.
Drug use among prisoners in three main prisons in Khartoum, Sudan.
La Revue de Santé de la Méditerranée orientale. 1998;4:122–7.
24. Lintonen TP, Vartiainen H, Aarnio J, Hakamäki S, Viitanen P, Wuolijoki T,
Joukamaa M. Drug use among prisoners: by any definition, it's a big
problem. Subst Use Misuse. 2011;46:440–51.
25. Sahajian F, Lamothe P, Fabry J, Vanhems P. Consumption of psychoactive
substances among 535 women entering a Lyon prison (France) between
June 2004 and December 2008. Rev Epidemiol Sante Publique.
2012;60:371–81.
26. Uganda Prisons Service. A rapid situation assessment of HIV/STI/TB and
drug abuse among prisoners in Uganda prisons service. Kampala: Uganda
Prisons Service and United Nations Office on Drugs and Crime; 2009.
27. Kinyanjui DWC, Atwoli L. Substance use among inmates at the Eldoret
prison in Western Kenya. BMC Psychiatry. 2013;13:53.
28. Coid J, Yang M, Ullrich S, Roberts A, Moran P, Bebbington P, Brugha T,
Jenkins R, Farrell M, Lewis G, Singleton N. Psychopathy among prisoners in
England and Wales. Int J Law Psychiatry. 2009;32:134–41.
29. Evren C, Kural S, Erkiran M. Antisocial personality disorder in Turkish
substance dependent patients and its relationship with anxiety, depression
and a history of childhood abuse. Isr J Psychiatry Relat Sci. 2006;43:40–6.
30. Galea S, Rudenstine S, Vlahov D. Drug use, misuse, and the urban
environment. Drug Alcohol Rev. 2005;24:127–36.
31. Ebiti NW, Ike JO, Sheikh TL, Lasisi DM, Babalola OJ, Agunbiade S.
Determinants of psychoactive substance use among incarcerated
delinquents in Nigeria. Afr J Drug Alcohol Stud. 2012;11(2):122–120.
32. Poikolainen K. Risk factors for alcohol dependence: a case-control study.
Alcohol Alcohol. 2000;35:190–6.
33. Piko B. Perceived social support from parents and peers: which is the
stronger predictor of adolescent substance use? Subst Use Misuse.
2000;35:617–30.
34. Mulia N, Schmidt L, Bond J, Jacobs L, Korcha R. Stress, social support and
problem drinking among women in poverty. Addiction. 2008;103:1283–93.
35. Belenko S, Peugh J. Fighting crime by treating substance abuse. Issues Sci
and Technol. 1998;15(1):53–60.
36. Kinner SA. Continuity of health impairment and substance misuse among
adult prisoners in Queensland, Australia. Int J Prison Health. 2006;2:101–13.
37. Thomas E, Degenhardt L, Alati R, Kinner S. Predictive validity of the AUDIT
for hazardous alcohol consumption in recently released prisoners. Drug
Alcohol Depend. 2014;134:322–9.
38. Galassi A, Mpofu E, Athanasou J. Therapeutic community treatment of an
inmate population with substance use disorders: post-release trends in
re-arrest, re-incarceration, and drug misuse relapse. Int J Environ Res Public
Health. 2015;12:7059–72.
Yitayih et al. BMC Psychiatry  (2018) 18:314 Page 9 of 9
